Claritas Pharmaceuticals Stock Toronto S.E.
Equities
KLY
CA1806341071
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.62M |
---|---|---|---|---|---|
Net income 2019 | -21M -28.64M | Net income 2020 | 4M 5.46M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 960K | Net Debt 2020 | 920K 1.25M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |